Cardiovascular benefits can increase Rybelsus’ competitiveness over other oral GLP-1RAs GlobalData Oct 29, 2024 The market for oral GLP-1RAs is expanding, and Rybelsus’ latest results showed its benefits in reducing the risk in cardiovascular…
